Abstract:Objectives: The optimal approach for resuscitation in septic shock remains unclear despite multiple randomized controlled trials (RCTs). Our objective was to investigate whether previously uncharacterized variation across individuals in their response to resuscitation strategies may contribute to conflicting average treatment effects in prior RCTs. Design: We randomly split study sites from the Australian Resuscitation of Sepsis Evaluation (ARISE) and Protocolized Care for Early Septic Shock (ProCESS) trials into derivation and validation cohorts. We trained machine learning models to predict individual absolute risk differences (iARDs) in 90-day mortality in derivation cohorts and tested for heterogeneity of treatment effect (HTE) in validation cohorts and swapped these cohorts in sensitivity analyses. We fit the best-performing model in a combined dataset to explore roles of patient characteristics and individual components of early goal-directed therapy (EGDT) to determine treatment responses. Setting: Eighty-one sites in Australia, New Zealand, Hong Kong, Finland, Republic of Ireland, and the United States. Patients: Adult patients presenting to the emergency department with severe sepsis or septic shock. Interventions: EGDT vs. usual care. Measurements and main results: A local-linear random forest model performed best in predicting iARDs. In the validation cohort, HTE was confirmed, evidenced by an interaction between iARD prediction and treatment (p < 0.001). When patients were grouped based on predicted iARDs, treatment response increased from the lowest to the highest quintiles (absolute risk difference [95% CI], -8% [-19% to 4%] and relative risk reduction, 1.34 [0.89-2.01] in quintile 1 suggesting harm from EGDT, and 12% [1-23%] and 0.64 [0.42-0.96] in quintile 5 suggesting benefit). Sensitivity analyses showed similar findings. Pre-intervention albumin contributed the most to HTE. Analyses of individual EGDT components were inconclusive. Conclusions: Treatment response to EGDT varied across patients in two multicenter RCTs with large benefits for some patients while others were harmed. Patient characteristics, including albumin, were most important in identifying HTE.

Early Goal-Directed Therapy in the Treatment of Severe Sepsis and Septic Shock

Early Goal-Directed Resuscitation for Patients with Severe Sepsis and Septic Shock: a Meta-Analysis and Trial Sequential Analysis

Early Management of Sepsis with Emphasis on Early Goal Directed Therapy: AME Evidence Series 002

A Multicentre Study on Early Goal-Directed Therapy of Severe Sepsis and Septic Shock Patients in the ICU: Collaborative Study Group on Early Goal-Directed Therapy in Zhejiang Province, China

Effects of Goal Directed Therapy for Adult Patients in Sepsis: A Systemic Review and Meta-Analysis of Randomized Controlled Trials

Success of applying early goal-directed therapy for septic shock patients in the emergency department

Early goal-directed therapy vs usual care in the treatment of severe sepsis and septic shock: a systematic review and meta-analysis

Early, Goal-Directed Therapy for Septic Shock - A Patient-Level Meta-Analysis

Early outcome of early-goal directed therapy for patients with sepsis or septic shock: a systematic review and meta-analysis of randomized controlled trials

Early Goal-Directed and Lactate-Guided Therapy in Adult Patients with Severe Sepsis and Septic Shock: a Meta-Analysis of Randomized Controlled Trials

Heterogeneity in the Effect of Early Goal-Directed Therapy for Septic Shock: A Secondary Analysis of Two Multicenter International Trials

Early Diagnosis and Treatment of Severe Sepsis

Individualized Fluid Administration for Critically Ill Patients with Sepsis with an Interpretable Dynamic Treatment Regimen Model

Practical Considerations in Sepsis Resuscitation

The Effect of Fluid Resuscitation Timing in Early Sepsis Resuscitation

[Protocol of the management of patients with severe sepsis and septic shock]

SEPSIS UNIT IN THE EMERGENCY DEPARTMENT: IMPACT ON MANAGEMENT AND OUTCOME OF SEPTIC PATIENTS

Management of Sepsis in the First 24 Hours: Bundles of Care and Individualized Approach

Fluids and Early Vasopressors in the Management of Septic Shock: Do We Have the Right Answers Yet?

When to stop septic shock resuscitation: clues from a dynamic perfusion monitoring

New treatment strategies for severe sepsis and septic shock